Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team

Bleiziffer, Sabine; Ruge, Hendrik; Mazzitelli, Domenico; Schreiber, Christian; Hutter, Andrea; Laborde, Jean-Claude; Bauernschmitt, Robert; Lange, Ruediger
April 2009
European Journal of Cardio-Thoracic Surgery;Apr2009, Vol. 35 Issue 4, p615
Academic Journal
Abstract: Objective: Transcatheter aortic valve implantation has been performed by several groups, most of them either specializing on the transapical (surgeons) or the percutaneous femoral transarterial approach (cardiologists). We achieved both transapical and percutaneous transcatheter valve implantation by a surgical team in a hybrid suite. Methods: Since June 2007, 137 patients (n =78 female, mean age 81±7 years) underwent transcatheter aortic valve implantation (n =109 transfemoral, n =3 via subclavian artery, n =2 directly through ascending aorta, n =23 transapical) with the CoreValve (n =114) or the Edwards Sapien (n =23) prosthesis. Results: Thirty-day mortality was 12.4% in this patient cohort. One hundred and eight patients (78.8%) are alive at a mean follow-up of 97±82 days. Pacemaker implantation due to postoperative AV block was performed in 27 patients (19.7%), and 7 patients (5.1%) sustained neurological events. Patients improved in NYHA class (from 3.1±0.3 to 1.9±0.5, p <0.001) and in self-assessed health state (from 55±17% to 68±16%, p <0.001) at one-month follow-up. Echocardiographic assessment revealed excellent hemodynamic function of the prostheses with a mean aortic gradient (MAG) of 11.9±4.4mmHg and an effective orifice area (EOA) of 1.6±0.4cm2 at discharge and a MAG of 11.0±4.2mmHg and an EOA of 1.6±0.3cm2 at six months FU. Conclusions: Transcatheter aortic valve implantation has become an alternative technique for the treatment of aortic stenosis with reasonable short- and mid-term results at our institution. With the opportunity to treat aortic stenosis by conventional surgical valve replacement and transapical and percutaneous transcatheter procedures, the technique of lowest risk for the individual patient can be chosen and performed by one team.


Related Articles

  • Anesthetic management and perioperative complications in transcatheter aortic valve implantation: the Turkish experience. GÜMÜŞ, Tülin; KESİMCİ, Elvin; SOYKUT, Cem; KANBAK, Orhan; BUT, Abdülkadir // Turkish Journal of Medical Sciences;2014, Vol. 44 Issue 4, p703 

    Background/aim: To describe the anesthetic management and early results of transcatheter aortic valve implantation (TAVI) in a single center in Turkey. Materials and methods: We evaluated 79 (54 females, 25 males; mean age: 76 ± 9 years) consecutive symptomatic patients with severe aortic...

  • First registry results from the newly approved ACURATE TAâ„¢ TAVI system. Kempfert, Jörg; Holzhey, David; Hofmann, Steffen; Girdauskas, Evaldas; Treede, Hendrik; Schröfel, Holger; Thielmann, Matthias; Walther, Thomas // European Journal of Cardio-Thoracic Surgery;Jul2015, Vol. 48 Issue 1, p137 

    OBJECTIVES: The novel ACURATE TATM transcatheter aortic valve (Symetis, Ecublens, Switzerland) is composed of a self-expanding nitinol stent covered by an anti-paravalvular leak skirt designed for transapical implantation. Since Conformite Europeenne (CE)-mark approval, the first 250 patients...

  • Prospective evaluation of aortic stenosis in end-stage kidney disease: a more fulminant process? Zentner, Dominica; Hunt, David; Chan, William; Barzi, Federica; Grigg, Leeanne; Perkovic, Vlado // Nephrology Dialysis Transplantation;May2011, Vol. 26 Issue 5, p1651 

    Background. We have previously demonstrated an increased rate of progression of aortic stenosis (AS) in patients with end-stage kidney disease (CKD 5D) compared to controls. We sought to follow prospectively a CKD 5D cohort with AS and determine major event-free survival. Follow-up was...

  • Single-centre experience with next-generation devices for transapical aortic valve implantation†. Seiffert, Moritz; Conradi, Lenard; Kloth, Benjamin; Koschyk, Dietmar; Schirmer, Johannes; Schnabel, Renate B.; Blankenberg, Stefan; Reichenspurner, Hermann; Diemert, Patrick; Treede, Hendrik // European Journal of Cardio-Thoracic Surgery;Jan2015, Vol. 47 Issue 1, p39 

    OBJECTIVES Transcatheter aortic valve implantation (TAVI) has become an established procedure in patients with aortic stenosis and high surgical risk. Experience with first-generation transcatheter heart valves (THVs) is broad but limitations, e.g. paravalvular regurgitation, have been...

  • Three-year haemodynamic performance of the St Jude Trifecta bioprosthesis. Ruggieri, Vito Giovanni; Anselmi, Amedeo; Chabanne, Celine; Lelong, Bernard; Flecher, Erwan; Verhoye, Jean-Philippe; Leguerrier, Alain // European Journal of Cardio-Thoracic Surgery;Mar2016, Vol. 49 Issue 3, p972 

    OBJECTIVES: To examine the haemodynamic performance of the St Jude Trifecta valve for aortic valve replacement (AVR) at 3 years after implantation. METHODS: In a single-centre, prospective, observational, independent study, we enrolled 122 patients who had AVR using a Trifecta bioprosthesis in...

  • Značaj natriuretskih peptida u proceni težine aortne stenoze. Davičević, Žaklina; Tavčiovski, Dragan; Matunović, Radomir; Vukotić, Snježana; Mijailović, Zdravko // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Aug2010, Vol. 67 Issue 8, p622 

    Background/Aim. Symptom onset is a critical point in natural course of aortic stenosis and the most important indication for aortic valve replacement. The aim of the study was to evaluate the role of natriuretic peptides level in the assessment of symtomatic status of patients with severe aortic...

  • Rane promjene u deformaciji i funkciji miokarda nakon zamjene aortne valvule zbog teÅ¡ke aortne stenoze. Lukšić, Vlatka Rešković; Došen, Dejan; Večerić, Sandra; Pašalić, Marijan; Hanževački, Jadranka Šeparović // Cardiologia Croatica;Sep/Oct2014, Vol. 9 Issue 9/10, p383 

    INTRODUCTION: In patients with severe aortic stenosis (AS) and preserved left ventricular systolic function (LVEF), myocardial deformation parameters like global longitudinal strain (GLS) are often reduced, due to pressure overload or subtle irreversible systolic dysfunction. After aortic valve...

  • Preoperative left atrial volume index predicts postoperative atrial fibrillation in patients with severe aortic valve stenosis. Naito, Yoshifumi; Yamazaki, Kazuo // Journal of Anesthesia;2013, Vol. 27 Issue 5, p699 

    Purpose: Left atrial enlargement correlates with the severity of diastolic dysfunction and is a predictor of cardiovascular complications such as atrial fibrillation. Aortic valve stenosis (AS) causes left atrial enlargement and progression of diastolic dysfunction. The aim of this study was to...

  • Therapeutic decisions for patients with symptomatic severe aortic stenosis: room for improvement? van Geldorp, Martijn W.A.; van Gameren, Menno; Kappetein, Arie Pieter; Arabkhani, Bardia; de Groot-de Laat, Lotte E.; Takkenberg, Johanna J.M.; Bogers, Ad J.J.C. // European Journal of Cardio-Thoracic Surgery;Jun2009, Vol. 35 Issue 6, p953 

    Abstract: Objective: Symptomatic severe aortic stenosis is an indication for aortic valve replacement. Some patients are denied intervention. This study provides insight into the proportion of conservatively treated patients and into the reasons why conservative treatment is chosen. Methods: Of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics